Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
BREAKING: State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office for Repirinast and the Treatment of CKD
COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer
Psychedelic Bulletin #138: Delix’s Non-Hallucinogenic Psychedelic Enters the Clinic; Arizona Earmarks $5m for Whole Mushroom Psilocybin Trials; MEPs form EU Action Group
Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21
PT412 – Psychedelics and Virtual Reality: Where Novel Experience, Technology, and...
Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part...
FILAMENT HEALTH ANNOUNCES INTERIM RESULTS FROM PHASE I CLINICAL TRIAL AT...
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
Psychedelics Weekly – New LSD Research and The Challenges Facing a...
Terran Biosciences announces new breakthroughs in the chemistry of MDMA and...
Sunstone Therapies presents data at ASCO showing positive long-term follow-up results...
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single...
Small Pharma Announces Significant Developments In Intellectual Property Portfolio
Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted...
1
2
3
...
215
Page 1 of 215